The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
The Autophagy–Lysosomal Pathway in Neurodegeneration: A TFEB Perspective
Open accessAbstract
The autophagy-lysosomal pathway (ALP) is involved in the degradation of long-lived proteins. Deficits in the ALP result in protein aggregation, the generation of toxic protein species, and accumulation of dysfunctional organelles, which are hallmarks of Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and prion disease. Decades of research have therefore focused on enhancing the ALP in neurodegenerative diseases. More recently, transcription factor EB (TFEB), a major regulator of autophagy and lysosomal biogenesis, has emerged as a leading factor in addressing disease pathology. We review the regulation of the ALP and TFEB and their impact on neurodegenerative diseases. We also offer our perspective on the complex role of autophagy and TFEB in disease pathogenesis and its therapeutic implications through the examination of prion disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TFE3 or TFEB upregulation or activation through pharmacological inhibition of mTORC1 can trigger clearance of excess α-synuclein and halt the progression of neurotoxicity17–22.”
From PDCD4 triggers α-synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson’s disease (2024) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produce neurodegeneration in cell and animal model systems [74–81], supporting a role for autophagy dysfunction in the devel”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Self-citationThe Role of Atg Proteins in Autophagosome Formation
Mizushima, N., Yoshimori, T., & Ohsumi, Y. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154005 · Cited by 2,978
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., Sideris, D. P., Fogel, A. I., & Youle, R. J. (2015) · Nature · doi:10.1038/nature14893 · Cited by 2,774
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Cited by
Sorted by citations
Lysosomes as dynamic regulators of cell and organismal homeostasis
Ballabio, A., & Bonifacino, J. S. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0185-4 · Cited by 1,469
Self-citationTargeted protein degradation: mechanisms, strategies and application
Zhao, L., Zhao, J., Zhong, K., Tong, A., & Jia, D. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00966-4 · Cited by 1,035
Lysosomes as a therapeutic target
Bonam, S. R., Wang, F., & Muller, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0036-1 · Cited by 786
“TFEB has received particular attention in this regard [193] [194] [195] , with recent data suggesting that TFEB is selectively lost in patients with AD (as well as ALS) 196 .”
BackgroundAutophagy: The spotlight for cellular stress responses
Ravanan, P., Florance, I., & Talwar, P. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.08.029 · Cited by 595
Nixon, R. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700359 · Cited by 400
Role of lysosomes in physiological activities, diseases, and therapy
Zhang, Z., Yue, P., Lu, T., Wang, Y., Wei, Y., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01087-1 · Cited by 375
“The autophagylysosome pathway (ALP) is essential for the survival of non-dividing neurons by contributing to the removal of abnormal large protein aggregates and organelles [76, 77].”
BackgroundSelective autophagy as a potential therapeutic target for neurodegenerative disorders
Scrivo, A., Bourdenx, M., Pampliega, O., & Cuervo, A. M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30238-2 · Cited by 355
AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3
Paquette, M., El–Houjeiri, L., Zirden, L. C., Puustinen, P., Blanchette, P., Jeong, H., Dejgaard, K., Siegel, P. M., & Pause, A. (2021) · Autophagy · doi:10.1080/15548627.2021.1898748 · Cited by 264
“Interestingly, TFEB and TFE3 also play important roles in non-dividing neurons to clear toxins and misfolded proteins through regulation of autophagic pathways [17].”
BackgroundAutophagy Induction as a Therapeutic Strategy for Neurodegenerative Diseases
Djajadikerta, A., Keshri, S., Tanasa, M. P., Prestil, R., Ryan, L., & Rubinsztein, D. C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.035 · Cited by 244
“[141] Martini-Stoica H, Xu Y, Ballabio A, Zheng H.”
Wang, Y., Cheng, H., Wang, T., Zhang, K., Zhang, Y., & Kang, X. (2023) · Cell Proliferation · doi:10.1111/cpr.13448 · Cited by 243
“(TFEB) is the main transcription regulator of lysosome and autophagy genes.(168) Apigenin can promote the nuclear translocation of TFEB by”
BackgroundSTUB1 regulates TFEB‐induced autophagy–lysosome pathway
Sha, Y., Rao, L., Settembre, C., Ballabio, A., & Eissa, N. T. (2017) · The EMBO Journal · doi:10.15252/embj.201796699 · Cited by 231
“Methods to induce TFEB activation to enhance autophagy – lysosome-mediated degradation of misfolded proteins have been suggested for treatment of diseases associated with misfolded proteins such as neurodegenerative diseases (Decressac & Bjo¨rklund, 2013; Martini-Stoica et al , 2016).”
Self-citationZhang, W., Xu, C., Sun, J., Shen, H., Wang, J., & Yang, C. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.008 · Cited by 221
Autophagy in aging and longevity
Wong, S. Q., Kumar, A. V., Mills, J., & Lapierre, L. R. (2019) · Human Genetics · doi:10.1007/s00439-019-02031-7 · Cited by 210
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
Dysregulation of autophagy as a common mechanism in lysosomal storage diseases
Seranova, E., Connolly, K. J., Zatyka, M., Rosenstock, T. R., Barrett, T. G., Tuxworth, R. I., & Sarkar, S. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170055 · Cited by 183
Xu, Y., Propson, N. E., Du, S., Xiong, W., & Zheng, H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023418118 · Cited by 171
Self-citationZheng, X., Lin, W., Jiang, Y., Lu, K., Wei, W., Huo, Q., Cui, S., Yang, X., Li, M., Xu, N., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1886720 · Cited by 167
The Lysosome Signaling Platform: Adapting With the Times
Inpanathan, S., & Botelho, R. J. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00113 · Cited by 160
The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders
Vidoni, C., Follo, C., Savino, M., Melone, M. A. B., & Isidoro, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21394 · Cited by 164
Autophagy in Bone Remodeling: A Regulator of Oxidative Stress
Zhu, C., Shen, S., Zhang, S., Huang, M., Zhang, L., & Chen, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.898634 · Cited by 169
Lysosomes in senescence and aging
Tan, J. X., & Finkel, T. (2023) · EMBO Reports · doi:10.15252/embr.202357265 · Cited by 178
Victoria, G. S., & Zurzolo, C. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201701047 · Cited by 152
“Lysosomal stress can also alter TFEB signaling, which is directly responsible for increasing lysosomal exocytosis (Martini-Stoica et al., 2016).”
BackgroundZhu, L., Yuan, Y., Yuan, L., Li, L., Liu, F., Liu, J., Chen, Y., Lu, Y., & Cheng, J. (2020) · Theranostics · doi:10.7150/thno.44051 · Cited by 153
“TFEB is a known master transcriptional regulator of autophagy and can regulate lysosome biogenesis and promote autophagosome-lysosome activity by binding to the CLEAR element on a variety of autophagy and lysosomal genes to induce their expression [41, 42].”
BackgroundIssa, A.-R., Sun, J., Petitgas, C., Mesquita, A., Dulac, A., Robin, M., Mollereau, B., Jenny, A., Chérif‐Zahar, B., & Birman, S. (2018) · Autophagy · doi:10.1080/15548627.2018.1491489 · Cited by 156
Chandra, S., Roy, A., Jana, M., & Pahan, K. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.007 · Cited by 150
Autophagy impairment in Parkinson’s disease
Karabiyik, C., Lee, M. J., & Rubinsztein, D. C. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170023 · Cited by 141
“Translocation of TFEB to the nucleus enables its transcriptional activity, autophagosome formation and autophagosome-lysosome fusion (16).”
BackgroundHoller, C. J., Taylor, G., Deng, Q., & Kukar, T. L. (2017) · eNeuro · doi:10.1523/eneuro.0100-17.2017 · Cited by 137
“Lysosome dysfunction is a common occurrence in numerous neurodegenerative diseases (Platt et al., 2012; Martini-Stoica et al., 2016) and growing evidence indicates a critical role for PGRN in the maintenance of lysosome homeostasis (Ahmed et al.”
BackgroundChandra, S., Jana, M., & Pahan, K. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0054-18.2018 · Cited by 134
“Lysosomal adaptation under different physiological and pathological scenarios is dependent on a regulatory gene network known as CLEAR (coordinated lysosomal expression and regulation), with the master regulator TFEB at its core (Sardiello et al., 2009; Martini-Stoica et al., 2016).”
BackgroundIyaswamy, A., Thakur, A., Guan, X.-J., Krishnamoorthi, S., Fung, T. Y., Lu, K., Gaurav, I., Yang, Z., Su, C.-F., Lau, K.-F., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01657-4 · Cited by 134
“28,29 Interestingly, a relationship between exosomes and autophagy that is considered a key protein degradation pathway functioning to clear misfolded proteins in various neurodegenerative diseases including AD, has been studied.”
BackgroundExercise activates lysosomal function in the brain through AMPK‐SIRT1‐TFEB pathway
Huang, J., Wang, X., Zhu, Y., Li, Z., Zhu, Y., Wu, J., Qin, Z., Xiang, M., & Lin, F. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13114 · Cited by 130
Xu, Y., Du, S., Marsh, J. A., Horie, K., Sato, C., Ballabio, A., Karch, C. M. M., Holtzman, D. M., & Zheng, H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0738-0 · Cited by 124
Self-citationPost-translational modifications: Regulators of neurodegenerative proteinopathies
Gupta, R. V., Sahu, M., Srivastava, D., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101336 · Cited by 126
Members, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124
“The two main systems for the removal of misfolded proteins are: (1) the autophagy–lysosomal pathway (ALP), which removes dysfunctional proteins, aggregates, and even subcellular organelles; and (2) the ubiquitin proteasomal system (UPS), which catalyzes the tagging of target proteins by ubiquitination, followed by the…”
BackgroundRegulated cell death: discovery, features and implications for neurodegenerative diseases
Cui, J., Zhao, S., Li, Y., Zhang, D., Wang, B., Xie, J., & Wang, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00799-8 · Cited by 130
“Deficiencies in the autophagy-lysosomal pathway can contribute to the aggregation of abnormal protein, the generation of toxic substances and the accumulation of dysfunctional organelles [149].”
BackgroundZhang, Z., Yan, J., Bowman, A. B., Bryan, M. R., Singh, R., & Aschner, M. (2019) · Autophagy · doi:10.1080/15548627.2019.1688488 · Cited by 116
Roles of Autophagy-Related Genes in the Pathogenesis of Inflammatory Bowel Disease
Kim, S., Eun, H. S., & Jo, E. (2019) · Cells · doi:10.3390/cells8010077 · Cited by 128
A Self-Assembled α-Synuclein Nanoscavenger for Parkinson’s Disease
Liu, J., Liu, C., Zhang, J., Zhang, Y., Liu, K., Song, J., Sreenivasmurthy, S. G., Wang, Z., Shi, Y., Chu, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b06453 · Cited by 117
Gao, L., Li, X., Meng, S., Ma, T., Wan, L., & Xu, S. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s235969 · Cited by 115
Targeting Autophagy to Overcome Human Diseases
Condello, M., Pellegrini, E., Caraglia, M., & Meschini, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030725 · Cited by 117
“The EB transcription factor (TFEB) has been identified as the factor that positively regulates genes related to formation of autophagosomes and the lysosome fusion, increasing the clearance of lysosomal exocytosis [104].”
BackgroundYang, C., Su, C.-F., Iyaswamy, A., Krishnamoorthi, S. K., Zhu, Z., Yang, S., Tong, B. C., Liu, J., Sreenivasmurthy, S. G., Guan, X., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.017 · Cited by 117
Autophagy–lysosomal-associated neuronal death in neurodegenerative disease
Nixon, R. A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02799-7 · Cited by 126
“…controlling the “CLEAR Network” of genes encoding autophagy and especially lysosomal biogenesis constitutes a successful strategy to delay effects of cell aging or extend longevity in vivo in aging models [179] and to slow or prevent neurodegenerative disease progression in mouse models [149].”
Liu, Y., Zhou, H., Yin, T., Gong, Y., Yuan, G., Chen, L., & Liu, J. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.05.066 · Cited by 113
Penke, B., Bogár, F., Crul, T., Sántha, M., Tóth, M. E., & Vı́gh, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010325 · Cited by 112
“The first step is the formation of a crescent-shaped double membrane (phagophore or isolation membrane) derived from multiple sources, such as cytoplasmic membrane, mitochondria, or ER- and Golgi apparatus [96,122].”
BackgroundTFEB–vacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy
Wang, B., Martini‐Stoica, H., Qi, C., Lu, T., Wang, S., Xiong, W., Qi, Y., Xu, Y., Sardiello, M., Li, H., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01494-2 · Cited by 107
“Lysosomes play essential roles in cellular homeostasis through the LYNUS system and the coordinated mTOR-TFEB lysosome to nucleus signaling 24 .”
Self-citationRen, H., Zhai, W., Lu, X., & Wang, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.691881 · Cited by 106
Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies
Krohn, L., Öztürk, T. N., Vanderperre, B., Bencheikh, B. O. A., Ruskey, J. A., Laurent, S. B., Spiegelman, D., Postuma, R. B., Arnulf, I., Hu, M. T. M., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25629 · Cited by 105
“The autophagy lysosomal pathway (ALP) likely plays a major role in PD pathogenesis,(4) as deficits in the ALP may lead to α-synuclein aggregation and accumulation and reduction in glucocerebrosidase (GCase) activity.(5) GCase is encoded by GBA, which harbors variants that are among the most common risk factors for PD.”
BackgroundAn FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis
Wang, Y., Gunewardena, S., Li, F., Matye, D. J., Chen, C., Chao, X., Jung, T., Zhang, Y., Czerwiński, M., Ni, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17363-6 · Cited by 100
Rakshe, P. S., Dutta, B. J., Chib, S., Maurya, N., & Singh, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102255 · Cited by 107
Cai, Y. C., Yang, L., Hu, G., Chen, X., Niu, F., Yuan, L., Liu, H., Xiong, H., Arikkath, J., & Buch, S. J. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201605065 · Cited by 100
“Our understanding of the link between autophagy and synaptic structure and function in absence of neurodegeneration (Menzies et al., 2015; Martini-Stoica et al., 2016) has been limited.”
BackgroundTFEB protects nucleus pulposus cells against apoptosis and senescence via restoring autophagic flux
Zheng, G., Pan, Z., Zhan, Y., Tang, Q., Zheng, F., Zhou, Y., Wu, Y., Zhou, Y., Chen, D., Chen, J., et al. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.10.011 · Cited by 97
Caberlotto, L., Nguyen, T.-P., Lauria, M., Priami, C., Rimondini, R., Maioli, S., Cedazo-Mínguez, Á., Sita, G., Morroni, F., Corsi, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39828-5 · Cited by 99
Zhang, H., Ni, W., Yu, G., Geng, Y., Lou, J., Qi, J., Chen, Y., Li, F., Ye, H., Ma, H., et al. (2023) · Theranostics · doi:10.7150/thno.78370 · Cited by 101
“Transcription factor EB (TFEB), which is a component of the microphthalmia transcription factor family, is considered a master modulator of autophagy activity and lysosome biogenesis [28].”
BackgroundKrohn, L., Heilbron, K., Blauwendraat, C., Reynolds, R. H., Yu, E., Senkevich, K. A., Rudakou, U., Estiar, M. A., Gustavsson, E. K., Brolin, K. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34732-5 · Cited by 104
TFEB, a potential therapeutic target for osteoarthritis via autophagy regulation
Zheng, G., Zhan, Y., Li, X., Pan, Z., Zheng, F., Zhang, Z., Zhou, Y., Wu, Y., Wang, X., Gao, W., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0909-y · Cited by 94
Li, C., Wang, X., Li, X., Qiu, K., Jiao, F., Liu, Y., Kong, Q., Liu, Y., & Wu, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00170 · Cited by 93
Emerging pathways driving early synaptic pathology in Alzheimer's disease
Briggs, C. A., Chakroborty, S., & Stutzmann, G. E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.088 · Cited by 95
“Lysosome dysfunction is implicated along multiple lines of evidence in neurodegenerative disease - AD, Parkinson’s Disease and Huntington’s Disease in particular [13,32,48,65,72,93,119].”
BackgroundTherapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols
Ajami, M., Pazoki–Toroudi, H., Amani, H., Nabavi, S. F., Braidy, N., Vacca, R. A., Atanasov, A. G., MOCAN, A., & Nabavi, S. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.022 · Cited by 94
“ALP impairment esults in aggregation of toxic protein species, and accumulation f damaged organelles such as dysfunctional mitochondria that ead to development and progression of neurodegenerative disorers (Martini-Stoica et al., 2016).”
Enhancing autophagy in Alzheimer's disease through drug repositioning
Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89
Targeting Undruggable Transcription Factors with PROTACs: Advances and Perspectives
Li, Y., Song, J. H., Zhou, P., Zhou, J., & Xie, S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00691 · Cited by 91
Recent advances in organelle-targeted organic photosensitizers for efficient photodynamic therapy
Dirak, M., Yenici, C. M., & Kölemen, S. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215710 · Cited by 90
Xu, Y., Ren, J., He, X., Chen, H., Wei, T., & Feng, W. (2019) · Autophagy · doi:10.1080/15548627.2019.1569928 · Cited by 89
Self-citationTranscription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies
Arotcarena, M.-L., Bourdenx, M., Dutheil, N., Thiolat, M.-L., Doudnikoff, E., Dovero, S., Ballabio, A., Fernagut, P.-O., Meissner, W. G., Bezard, E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129719 · Cited by 84
“Since TFEB is a master gene in the regulation of ALP (17–20, 22), we Because alteration of lysosomal integrity, and lysosomal membrane permeabilization especially, have been described in synucleinopathies (38, 39), we next explored whether overexpression of TFEB could rescue lysosomal membrane…”
Self-citationKim, J. H., Yu, D.-H., Huh, Y. H., Lee, E., Kim, H., & Kim, H. R. (2017) · Scientific Reports · doi:10.1038/srep41129 · Cited by 94
Jarazo, J., Barmpa, K., Modamio, J., Saraiva, C., Sabaté‐Soler, S., Rosety, I., Griesbeck, A., Skwirblies, F., Zaffaroni, G., Smits, L. M., et al. (2021) · Movement Disorders · doi:10.1002/mds.28810 · Cited by 98
“compound HP-β-CD was reported to modulate autophagy by increasing TFEB nuclear translocation in human neuroglioma cells.(29,35,36) Treatment with HPβ-CD during the entire differentiation process was able to increase the proportion of nuclei that colocalized with TFEB in a two-dimensional neuronal culture at 21 days of…”
BackgroundResultLysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance
Lakpa, K. L., Khan, N., Afghah, Z., Chen, X., & Geiger, J. D. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09990-7 · Cited by 81
Pi, H., Li, M., Tian, L., Yang, Z., Yu, Z., & Zhou, Z. (2017) · Scientific Reports · doi:10.1038/srep43466 · Cited by 80
Li, X., Zhang, X., Zheng, L., Kou, J., Zhong, Z., Jiang, Y., Wang, W., Dong, Z., Liu, Z., Han, X. B., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.433 · Cited by 79
“Transcription factor EB (TFEB) is a recently discovered key regulator of autophagy-lysosome pathway to promote protein clearance.(25,41) TFEB could upregulate the expression of nearly two-thirds of autophagy-”
BackgroundTFEB is a master regulator of tumor-associated macrophages in breast cancer
Li, Y., Hodge, J., Liu, Q., Wang, J., Wang, Y., Evans, T. D., Altomare, D., Yao, Y., Murphy, E. A., Razani, B., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000543 · Cited by 84
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Teil, M., Arotçarena, M.-L., Faggiani, E., Laferrière, F., Bézard, E., & Dehay, B. (2020) · Biomolecules · doi:10.3390/biom10030391 · Cited by 80
Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms
Zhang, X.-W., 澳门大学中华医药研究院中药质量研究国家重点实验室, 澳. 凼. 9., State Key Laboratory of Quality Research in Chinese Medicine, I. O. C. M. S., Zhu, X.-X., Tang, D.-S., Lu, J.-H., 佛山大学广东省动物分子设计与精准育种重点实验室, 广., & Guangdong Provincial Key Laboratory of Animal Molecular Design and Precise Breeding, G. E. T. C. O. G. P. (2023) · Zoological Research · doi:10.24272/j.issn.2095-8137.2023.294 · Cited by 77
TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS
Cunningham, K. M., Maulding, K., Ruan, K., Şentürk, M., Grima, J. C., Sung, H., Zuo, Z., Song, H., Gao, J., Dubey, S. K., et al. (2020) · eLife · doi:10.7554/elife.59419 · Cited by 80
Yadavalli, N., & Ferguson, S. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303789120 · Cited by 77
Trivedi, P. C., Bartlett, J. J., Perez, L. J., Brunt, K. R., Legare, J. F., Hassan, A., Kienesberger, P. C., & Pulinilkunnil, T. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.004 · Cited by 75
Brijmohan, A. S., Batchu, S. N., Majumder, S., Alghamdi, T. A., Thieme, K., McGaugh, S., Liu, Y., Advani, S. L., Bowskill, B. B., Kabir, M. G., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00034 · Cited by 71
“Cellular stress inactivates mTORC1, leading to dephosphorylation of TFEB, its release from 14-3-3 proteins and translocation of the transcription factor to the nucleus (Settembre et al., 2011; Martini-Stoica et al., 2016).”
BackgroundBodas, M., Patel, N., Silverberg, D., Walworth, K., & Vij, N. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6842 · Cited by 70
“The aberrant expression/activity of TFEB is evident in several pathological conditions, especially in age-related degenerative or lysosomal storage disorders, where TFEB impairment leads to accumulation of misfolded or damaged proteins in aggresome-bodies (34, 47).”
Grimm, C. M., Butz, E. S., Chen, C., Wahl‐Schott, C., & Biel, M. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.04.003 · Cited by 70
Xu, Y., Zhang, S., & Zheng, H. (2018) · Autophagy · doi:10.1080/15548627.2018.1532258 · Cited by 69
“The autophagy-lysosomal pathway (ALP) is a highly conserved degradation pathway that acts by engulfing cellular substrates within MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3 beta)-positive double-membrane autophagosomes before delivering them to the lysosome for eventual degradation [5,6].”
BackgroundSelf-citationMitochondria–lysosome membrane contacts are defective in GDAP1-related Charcot–Marie–Tooth disease
Cantarero, L., Juárez‐Escoto, E., Civera-Tregón, A., Rodríguez-Sanz, M., Roldán, M., Benítez, R., Hoenicka, J., & Palau, F. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa243 · Cited by 73
Yin, Y., Tian, B., Li, X., Yu, Y.-C., Deng, D., Sun, L., Qu, H., Wu, R., Xu, X., Sun, H., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121743 · Cited by 68
Adiponectin alleviated Alzheimer‐like pathologies via autophagy‐lysosomal activation
He, K., Nie, L., Ali, T., Wang, S., Chen, X., Liu, Z., Li, W., Zhang, K., Xu, J., Liu, J., et al. (2021) · Aging Cell · doi:10.1111/acel.13514 · Cited by 64
The fluorescence toolbox for visualizing autophagy
Ding, S., & Hong, Y. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00913j · Cited by 63
TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications
Gu, Z., Cao, H., Zuo, C., Huang, Y., Miao, J., Song, Y., Yang, Y., Zhu, L., & Wang, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105855 · Cited by 69
“Recently, studies have demonstrated the roles of TFEB and ALP dysfunction in the development of several neurodegenerative diseases, including AD (Boland et al., 2018; Martini-Stoica et al., 2016; Song et al., 2021).”
BackgroundNatural products for the treatment of neurodegenerative diseases
Cui, D., Chen, Y., Ye, B., Guo, W., Wang, D., & He, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155101 · Cited by 71
Yuan, Y., Li, L., Zhu, L., Liu, F., Tang, X., Liao, G., Liu, J., Cheng, J., Chen, Y., & Lu, Y. (2020) · Stem Cells · doi:10.1002/stem.3144 · Cited by 63
“TFEB activity is regulated by mTORC1-mediated phosphorylation at specific serine residues in response to changes in nutritional status.(16)”
BackgroundSu, C., Feng, Y. Y., Liu, T., Liu, X., Bao, J., Shi, A., Hu, D., Liu, T., & Yu, Y. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12721 · Cited by 61
Snouwaert, J. N., Church, R. J., Jania, L., Nguyen, M., Wheeler, M. L., Saintsing, A., Mieczkowski, P., Manuel de Villena, F. P., Armao, D., Moy, S. S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.118 · Cited by 52
“, 2016), Alzheimer’s disease (Martini-Stoica et al., 2016), amyotrophic lateral sclerosis (ALS) (Kiriyama and Nochi, 2015), hereditary spastic paraplegia (HSP) (Ebrahimi-Fakhari et al.”
BackgroundLiu, L., Tao, Z., Zheng, L., Brooke, J., Smith, C., Liu, D., Long, Y. C., & Cheng, Z. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.66 · Cited by 61
Melatonin as an endogenous regulator of diseases: The role of autophagy
Roohbakhsh, A., Shamsizadeh, A., Hayes, A. W., Reiter, R. J., & Karimi, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.022 · Cited by 59
Yang, C., Zhu, Z., Tong, B. C., Iyaswamy, A., Xie, W.-J., Zhu, Y., Sreenivasmurthy, S. G., Krishnamoorthi, S., Cheung, K., Song, J., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101445 · Cited by 60
Phillipson, O. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.006 · Cited by 60
Yuan, L., Yuan, Y., Liu, F., Li, L., Liu, J., Chen, Y., Cheng, J., & Lu, Y. (2021) · Aging · doi:10.18632/aging.202653 · Cited by 59
“Studies have demonstrated that TFEB promotes the expression of genes in the autophagy pathway, as well as genes encoding the components of lysosomes [29, 50, 51].”
BackgroundThe Role and Regulatory Mechanism of Transcription Factor EB in Health and Diseases
Zhu, S., Yao, R.-Q., Li, Y., Zhao, P., Ren, C., Du, X., & Yao, Y.-M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667750 · Cited by 56
“The activation and translocation of TFEB are sequentially initiated under exposure of cellular stress, such as starvation and lysosomal dysfunction (Martina et al., 2012; Roczniak-Ferguson et al., 2012; Medina et al., 2015).”
BackgroundInfluentialTranscription factor EB: an emerging drug target for neurodegenerative disorders
Song, J., Liu, J., Jiang, Y., Wang, Z., & Li, M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.013 · Cited by 59
Treadmill exercise reduces α-synuclein spreading via PPARα
Dutta, D., Paidi, R. K., Raha, S., Roy, A., Chandra, S., & Pahan, K. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111058 · Cited by 57
Zeng, X., Li, P., Ning, Y., Zhao, Y., Peng, Y., Yang, N., Zhao, Z., Chen, J., & Zhou, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0316-4 · Cited by 58
Autophagy in exposure to environmental chemicals
Pesonen, M., & Vähäkangas, K. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.01.007 · Cited by 57
Mao, X., Lei, H., Yi, T., Su, P., Tang, S., Tong, Y., Dong, B., Ruan, G., Mustea, A., Sehouli, J., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02211-2 · Cited by 55
“TFEB downregulation or deficiency can obviously affect the cellular phenotype in a physiologically relevant manner in settings including atherosclerosis [26], nonalcoholic fatty liver disease [27], cancer [28] and neurodegeneration [29].”
BackgroundMaterial properties of phase-separated TFEB condensates regulate the autophagy-lysosome pathway
Wang, Z., Chen, D., Guan, D., Liang, X., Xue, J., Zhao, H., Song, G., Lou, J., He, Y., & Zhang, H. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202112024 · Cited by 53
Pircs, K., Drouin‐Ouellet, J., Horváth, V., Gil, J., Rezeli, M., Garza, R., Grassi, D. A., Sharma, Y., St‐Amour, I., Harris, K. L., et al. (2021) · Brain · doi:10.1093/brain/awab473 · Cited by 54
Cui, Y., Arnold, F. J., Peng, F., Wang, D., Li, J. S., Michels, S., Wagner, E. J., Spada, A. R. L., & Li, W. (2023) · Nature Communications · doi:10.1038/s41467-023-36311-8 · Cited by 50
Metadata
- Authors
- Martini-Stoica, H., Xu, Y., Ballabio, A., & Zheng, H.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Zheng, Hui
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 39
- Issue
- 4
- Pages
- 221-234
- ISSN
- 0166-2236 (ISSN-L)
- PMC
- PMC4928589
- OpenAlex
- W2293027573
- Cited by
- 436
- References
- 127
- Citations by year
- 2026: 38 · 2025: 41 · 2024: 46 · 2023: 65 · 2022: 48 · 2021: 53 · 2020: 43 · 2019: 34 · 2018: 27 · 2017: 31 · 2016: 10
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (RF1AG020670, F30AG050412, R01AG020670)
- National Institute of Neurological Disorders and Stroke (R01NS076117, RF1NS093652, R01NS078072, R01NS093652)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- autophagy-lysosome pathway, TFEB, neurodegenerative diseases, lysosomal biogenesis, protein aggregation, Alzheimer's disease, Parkinson's disease, Huntington's disease, prion disease, autophagy regulation, therapeutic target
- MeSH terms
- Animals, Autophagy, Brain, Humans, Lysosomes, Nerve Degeneration, Neurodegenerative Diseases, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review